M. genitalium ups risk of pelvic inflammatory disease, cervicitis

<i>M. genitalium</i> ups risk of pelvic inflammatory disease, cervicitis
Infection with Mycoplasma genitalium is an independent and strong risk factor for both cervicitis and pelvic inflammatory disease, according to a study published in the June issue of the American Journal of Obstetrics & Gynecology.

(HealthDay) -- Infection with Mycoplasma genitalium (M. genitalium) is an independent and strong risk factor for both cervicitis and pelvic inflammatory disease (PID), according to a study published in the June issue of the American Journal of Obstetrics & Gynecology.

Carina Bjartling, M.D., Ph.D., from the University of Skane in Malmö, Sweden, and colleagues studied 5,519 women in a cross-sectional case-control study conducted in an outpatient gynecology center.

The researchers found that, among the women tested, the prevalence of M. genitalium was 2.1 percent and the prevalence of Chlamydia trachomatis (C. trachomatis) was 2.8 percent. In an analysis of 679 women, both PID and cervicitis were each independently associated with M. genitalium (odds ratios [ORs], 9.00 [95 percent confidence interval (CI), 1.62 to 49.89] and 3.80 [95 percent CI, 2.06 to 7.03], respectively). There was a significantly higher frequency of both PID (18.3 versus 4.9 percent) and cervicitis (33.4 versus 22.3 percent) in women with C. trachomatis than in with M. genitalium.

"M. genitalium was an independent and strong risk factor for both cervicitis and PID, although, compared to C. trachomatis, clinical manifestations were less frequent," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

New Chlamydia test shows type of infection

May 24, 2011

A new Chlamydia test can quickly and easily demonstrate the subtype (serovar) of the bacterium Chlamydia trachomatis a person is infected with. This has important clinical implications, because some Chlamydia subtypes, that ...

Recommended for you

Phthalates heighten risk for childhood asthma

1 hour ago

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used ...

ERS: Mepolizumab is glucocorticoid-sparing in asthma

Sep 09, 2014

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published ...

User comments